Biofrontera Stock Forecast, Price & News

Biofrontera (NASDAQ:BFRI) Frequently Asked Questions

Is Biofrontera a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Biofrontera in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Biofrontera stock.
View analyst ratings for Biofrontera or view top-rated stocks.

What price target have analysts set for BFRI?

1 brokerages have issued 1-year price targets for Biofrontera's stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Biofrontera's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 233.9% from the stock's current price.
View analysts' price targets for Biofrontera or view top-rated stocks among Wall Street analysts.

Who are some of Biofrontera's key competitors?

Some companies that are related to Biofrontera include Kamada (KMDA), KemPharm (KMPH), BioDelivery Sciences International (BDSI), Harrow Health (HROW), 89bio (ETNB), Sernova (SEOVF), 9 Meters Biopharma (NMTR), eFFECTOR Therapeutics (EFTR), Akouos (AKUS), Spectrum Pharmaceuticals (SPPI), Theratechnologies (THERF), Esperion Therapeutics (ESPR), PLx Pharma (PLXP), UroGen Pharma (URGN) and Connect Biopharma (CNTB).
View all of BFRI's competitors.

When did Biofrontera IPO?

(BFRI) raised $19 million in an initial public offering on Friday, October 29th 2021. The company issued 3,100,000 shares at a price of $5.00-$7.00 per share. Roth Capital Partners and The Benchmark Company acted as the underwriters for the IPO.

What is Biofrontera's stock symbol?

Biofrontera trades on the NASDAQ under the ticker symbol "BFRI."

When does the company's quiet period expire?

Biofrontera's quiet period expires on Wednesday, December 8th. Biofrontera had issued 3,600,000 shares in its public offering on October 29th. The total size of the offering was $18,000,000 based on an initial share price of $5.00. During the company's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Biofrontera?

Shares of BFRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biofrontera's stock price today?

One share of BFRI stock can currently be purchased for approximately $5.99.

How much money does Biofrontera make?

Biofrontera has a market capitalization of $69.48 million.

How many employees does Biofrontera have?

Biofrontera employs 2,021 workers across the globe.

What is Biofrontera's official website?

The official website for Biofrontera is www.biofrontera-us.com.

How can I contact Biofrontera?

The company can be reached via phone at 781-245-1325 or via email at [email protected].